Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Revenues | ||||
Product revenue, net | $ 13,482,282 | $ 8,156,173 | $ 42,149,561 | $ 12,771,235 |
Operating expenses | ||||
Cost of sales | 13,682,297 | 1,998,659 | 23,499,842 | 2,980,425 |
Research and development | 389,262 | 78,502 | 858,698 | 223,197 |
Selling, general and administrative | 12,851,087 | 9,190,386 | 35,825,175 | 19,494,368 |
Acquisition related costs | 1,536,800 | 311,083 | 2,849,037 | 1,533,723 |
Restructuring costs | 4,818,064 | 4,874,723 | 135,981 | |
Amortization and impairment of intangible assets | 5,870,436 | 1,370,986 | 9,039,597 | 2,899,553 |
Total operating expenses | 39,147,946 | 12,949,616 | 76,947,072 | 27,267,247 |
Loss from operations | (25,665,664) | (4,793,443) | (34,797,511) | (14,496,012) |
Other (expense) income | ||||
Other (expense), net | (425,425) | (538,862) | (1,555,924) | (1,181,206) |
Gain / (Loss) from change in fair value of contingent consideration | 631,298 | (2,680,022) | ||
Gain from derecognition of contingent consideration | 5,199,806 | |||
Gain from warrant derivative liability | 1,830 | |||
Loss on debt exchange | (257,559) | |||
Total other (expense) income | 205,873 | (538,862) | (4,493,505) | 4,020,430 |
Net loss | $ (25,459,791) | $ (5,332,305) | $ (39,291,016) | $ (10,475,582) |
Weighted average number of common shares outstanding (in shares) | 18,092,465 | 3,527,530 | 14,490,219 | 2,261,697 |
Basic and diluted net loss per common share (in dollars per share) | $ (1.41) | $ (1.51) | $ (2.71) | $ (4.63) |
X | ||||||||||
- Definition Represents amortization and impairment of intangible assets during the period. No definition available.
|
X | ||||||||||
- Definition The amount of gain (loss) from derecognition of contingent consideration. No definition available.
|
X | ||||||||||
- Definition The amount of gain (loss) on exchange of debt. No definition available.
|
X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|